Prioritised research agenda for prevention and control of chronic respiratory diseases

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 995-1001

  Bousquet, J ^a   Kiley, J ^b   Bateman, E D ^c   Viegi, G ^d,e   Cruz, A A ^f   Khaltaev, N ^g   Ait Khaled N ^h   Baena Cagnani, C E ⁱ   Barreto, M L ^f   Billo, N ^h   Canonica, G W ^j   Carlsen, K H ^k   Chavannes, N ^l   Chuchalin, A ^m   Drazen, J ⁿ   Fabbri, L M ^o   Gerbase, M W ^p   Humbert, M ^q   Joos, G ^r   Masjedi, M R ^s   Makino, S ^t   Rabe, K ^l   To, T ^u   Zhi, L ^v   more..

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e Biomedicine and Molecular Immunology   (Italy)

^f FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^g Allergic Rhinitis and Its Impact on Asthma   (Switzerland)

^h INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

ⁱ UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^j UNIVERSITY OF GENOA   (Italy)

^k UNIVERSITY OF OSLO   (Norway)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m Pulmonology Research Institute   (Russian Federation)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

^o UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^p GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^q UNIVERSITÉ PARIS SACLAY   (France)

^r GHENT UNIVERSITY HOSPITAL   (Belgium)

^s SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^t Dokkyo University   (Japan)

^u HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^v Chinese Medical Association   (China)

more..

Author keywords

Asthma; Chronic obstructive pulmonary disease; Chronic respiratory diseases; Noncommunicable diseases; Prevention; Research

Indexed keywords

ASTHMA; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COMORBIDITY; DISEASE CONTROL; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INTERSTITIAL LUNG DISEASE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; OCCUPATIONAL ASTHMA; PATIENT EDUCATION; PHYSICAL DISABILITY; PNEUMOCONIOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY HYPERTENSION; RESEARCH PRIORITY; REVIEW; RHINITIS; RISK FACTOR; SLEEP DISORDERED BREATHING; SMOKING; WORLD HEALTH ORGANIZATION;

CHRONIC DISEASE; COMORBIDITY; HUMANS; LUNG DISEASES; PREVALENCE; RESEARCH; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 78349233159     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00012610     Document Type: Review

References (60)

1. Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. www.who.int/gard/ publications/GARD%20Book%202007.pdf Date last updated: 2007.
2. World Health Organization. Preventing chronic diseases: a vital investment. www.who.int/chp/chronic-disease-report/full-report.pdf Date last accessed: July 10, 2009. Date last updated: October 5, 2005.
3. Torres-Duque C, Maldonado D, Perez-Padilla R, et al. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008; 5: 577-590.
4. Crummy F, Piper AJ, Naughton MT. Obesity and the lung: 2. Obesity and sleep-disordered breathing. Thorax 2008; 63: 738-746.
5. Bush A. COPD: a pediatric disease. COPD 2008; 5: 53-67.
6. Martinez FD. Genes, environments, development and asthma: a reappraisal. Eur Respir J 2007; 29: 179-184.
7. von Mutius E, Le Souef PN. Early gene-environment interactions: can they inform primary preventive strategies for asthma? Semin Respir Crit Care Med 2007; 28: 255-263.
8. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007; 85: 279-288.
9. Ait-Khaled N, Enarson DA, Bissell K, et al. Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries. Allergy 2007; 62: 230-236.
10. NAEPP (National Asthma Education and Prevention Program). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm Date last accessed: July 10, 2009. Date last updated: 2007.
11. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
12. Coffman JM, Cabana MD, Halpin HA, et al. Effects of asthma education on children's use of acute care services: a meta-analysis. Pediatrics 2008; 121: 575-586.
13. Partridge M, Hill SR. Enhancing care for people with asthma: the role of communication, education, training and self-management. Eur Respir J 2000; 16: 333-348.
14. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133.
15. Gotzsche PC, Johansen HK. House dust mite control measures for asthma: systematic review. Allergy 2008; 63: 646-659.
16. Wong CM, Lam TH, Peters J, et al. Comparison between two districts of the effects of an air pollution intervention on bronchial responsiveness in primary school children in Hong Kong. J Epidemiol Community Health 1998; 52: 571-578.
17. Aït-Khaled N, Enarson DA, Chiang CY, et al. Management of asthma: a guide to the essentials of good clinical practice. 3rd Edn. Paris, International Union Against Tuberculosis and Lung Disease, 2008.
18. Ait-Khaled N, Enarson DA, Bencharif N, et al. Treatment outcome of asthma after one year follow-up in health centres of several developing countries. Int J Tuberc Lung Dis 2006; 10: 911-916. (Pubitemid 44197853)
19. Ait-Khaled N, Enarson DA. Ensuring the quality of asthma case management. Int J Tuberc Lung Dis 2006; 10: 726-731.
20. Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670.
21. Evans R III, Gergen PJ, Mitchell H, et al. A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-City Asthma Study. J Pediatr 1999; 135: 332-338. (Pubitemid 30180507)
22. Fischer GB, Camargos PA, Mocelin HT. The burden of asthma in children: a Latin American perspective. Paediatr Respir Rev 2005; 6: 8-13.
23. Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health 2007; 7: 82.
24. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
25. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
26. Chan-Yeung M, Ait-Khaled N, White N, et al. Management of chronic obstructive pulmonary disease in Asia and Africa. Int J Tuberc Lung Dis 2004; 8: 159-170. (Pubitemid 38622923)
27. World Health Organization. WHO Report on the Global Tobacco Epidemic. http://whqlib.who.int/publications/2009/9789241563918-eng-full.pdf Date last updated: 2008.
28. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
29. Kenfield SA, Stampfer MJ, Rosner BA, et al. Smoking and smoking cessation in relation to mortality in women. JAMA 2008; 299: 2037-2047. (Pubitemid 351656585)
30. Menzies D, Nair A, Williamson PA, et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA 2006; 296: 1742-1748. (Pubitemid 44547794)
31. Wipfli H, Samet JM. Global economic and health benefits of tobacco control: part 2. Clin Pharmacol Ther 2009; 86: 272-280.
32. Peytremann-Bridevaux I, Staeger P, Bridevaux PO, et al. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med 2008; 121: 433-443. (Pubitemid 351626013)
33. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
34. Chapman RS, He X, Blair AE, et al. Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ 2005; 331: 1050.
35. Pietinalho A, Kinnula VL, Sovijarvi AR, et al. Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report. Respir Med 2007; 101: 1419-1425.
36. Davis CL, Tkacz J, Gregoski M, et al. Aerobic exercise and snoring in overweight children: a randomized controlled trial. Obesity (Silver Spring) 2006; 14: 1985-1991. (Pubitemid 46121930)
37. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361-366. (Pubitemid 38134815)
38. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit CareMed 2007; 176: 706-712. (Pubitemid 47503079)
39. Laitinen LA, Anttalainen U, Pietinalho A, et al. Sleep apnoea: Finnish national guidelines for prevention and treatment 2002- 2012. Respir Med 2003; 97: 337-365.
40. Juniper CP, How MJ, Goodwin BF, et al. Bacillus subtilis enzymes: a 7-year clinical, epidemiological and immunological study of an industrial allergen. J Soc Occup Med 1977; 27: 3-12.
41. Merget R, Caspari C, Dierkes-Globisch A, et al. Effectiveness of a medical surveillance program for the prevention of occupational asthma caused by platinum salts: a nested case-control study. J Allergy Clin Immunol 2001; 107: 707-712. (Pubitemid 32397761)
42. Engle WA. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008; 121: 419-432.
43. Asher I, Baena-Cagnani C, Boner A, et al. World Allergy Organization guidelines for prevention of allergy and allergic asthma. Int Arch Allergy Immunol 2004; 135: 83-92. (Pubitemid 39279435)
44. Chan-Yeung M, Ferguson A, Watson W, et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol 2005; 116: 49-55. (Pubitemid 40909746)
45. Haahtela T, von Hertzen L, Makela M, et al. Finnish Allergy Programme 2008-2018: time to act and change the course. Allergy 2008; 63: 634-645.
46. Kilabuko JH, Matsuki H, Nakai S. Air quality and acute respiratory illness in biomass fuel using homes in Bagamoyo, Tanzania. Int J Environ Res Public Health 2007; 4: 39-44. (Pubitemid 46919964)
47. Savitha MR, Nandeeshwara SB, Pradeep Kumar MJ, et al. Modifiable risk factors for acute lower respiratory tract infections. Indian J Pediatr 2007; 74: 477-482. (Pubitemid 47305114)
48. Emmelin A, Wall S. Indoor air pollution: a poverty-related cause of mortality among the children of the world. Chest 2007; 132: 1615-1623. (Pubitemid 350156020)
49. Armstrong Schellenberg JR, Adam T, Mshinda H, et al. Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Lancet 2004; 364: 1583-1594.
50. Fairall LR, Zwarenstein M, Bateman ED, et al. Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial. BMJ 2005; 331: 750-754. (Pubitemid 41414944)
51. Murray JF, Pio A, Ottmani S. PAL: a new and practical approach to lung health. Int J Tuberc Lung Dis 2006; 10: 1188-1191. (Pubitemid 44713472)
52. Pruss-Ustun A, Corvalan C. How much disease burden can be prevented by environmental interventions? Epidemiology 2007; 18: 167-178.
53. Nelson DI, Concha-Barrientos M, Driscoll T, et al. The global burden of selected occupational diseases and injury risks: methodology and summary. Am J Ind Med 2005; 48: 400-418. (Pubitemid 41746859)
54. Fingerhut M, Nelson DI, Driscoll T, et al. The contribution of occupational risks to the global burden of disease: summary and next steps. Med Lav 2006; 97: 313-321.
55. World Health Organization: The World Health Report 2002: Reducing risks, promoting healthy life. www.who.int/whr/2002/en/whr02-en.pdf Date last accessed: July 10, 2009. Date last updated: 2002.
56. Pruss-Ustun A, Bonjour S, Corvalan C. The impact of the environment on health by country: a meta-synthesis. Environ Health 2008; 7: 7. (Pubitemid 351467623)
57. Mendis S, Lindholm LH, Mancia G, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 2007; 25: 1578-1582.
58. World Health Organization. Prevention of cardiovascular disease: pocket guidelines for assessment and management of cardiovascular risk. www.who.int/cardiovascular-diseases/guidelines/PocketGL.ENGLISH.AFR-D-E.rev1. pdf Date last updated: 2007.
59. Woloshin S, Schwartz LM, Welch HG. Risk charts: putting cancer in context. J Natl Cancer Inst 2002; 94: 799-804. (Pubitemid 34705051)
60. Bheekie A, Buskens I, Allen S, et al. The Practical Approach to Lung Health in South Africa (PALSA) intervention: respiratory guideline implementation for nurse trainers. Int Nurs Rev 2006; 53: 261-268. (Pubitemid 44684069)